2015
DOI: 10.1016/j.bbrc.2015.08.124
|View full text |Cite
|
Sign up to set email alerts
|

Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
14
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 28 publications
2
14
0
Order By: Relevance
“…Spp24 may bind with BMP2 and, consequently, inhibit the function of BMP2. In addition, some studies have shown that spp24 could induce cancer cell apoptosis in vitro and in vivo (22). In our study, we also found that spp24 dramatically induced apoptosis of tumor cells; however, BMP2 did not affect cell apoptosis.…”
Section: Discussionsupporting
confidence: 74%
See 3 more Smart Citations
“…Spp24 may bind with BMP2 and, consequently, inhibit the function of BMP2. In addition, some studies have shown that spp24 could induce cancer cell apoptosis in vitro and in vivo (22). In our study, we also found that spp24 dramatically induced apoptosis of tumor cells; however, BMP2 did not affect cell apoptosis.…”
Section: Discussionsupporting
confidence: 74%
“…Spp24 can bind with BMP2 and inhibit its osteogenic activity (28,29). Several studies have indicated that spp24 could inhibit cancer cell proliferation and tumor growth (22,23). Lee et al showed that spp24 could ameliorate the effects of BMP2 on lung cancer in a subcutaneous and intratibial tumor model (23).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Coleusin factor, an inhibitor targeting BMP-2, exerted its anticancer effects on osteosarcoma by inducing osteoblast differentiation [135]. Moreover, phosphoprotein Spp24 secreted by BMP binding protein diminished BMP-2-initated tumor growth and thus resulted in significant apoptosis of cancer cells, which would be developed into a new therapeutic agent for clinical applications [136]. …”
Section: Therapeutic Approaches Against Bmp Signaling In Cancermentioning
confidence: 99%